88 related articles for article (PubMed ID: 7203965)
21. [*calcium-oxalate lithogenesis: crystallization in the presence of urine from healthy subjects].
Beaufays JP; Bouche R; Boistelle R
Nephrologie; 1995; 16(4):325-31. PubMed ID: 7630471
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of calcium oxalate crystal growth and aggregation by prothrombin and its fragments in vitro: relationship between protein structure and inhibitory activity.
Grover PK; Ryall RL
Eur J Biochem; 1999 Jul; 263(1):50-6. PubMed ID: 10429186
[TBL] [Abstract][Full Text] [Related]
23. The nucleation and growth kinetics of calcium oxalate in the presence of some synthetic urine constituents.
Rodgers AL; Garside J
Invest Urol; 1981 May; 18(8):484-8. PubMed ID: 7228583
[TBL] [Abstract][Full Text] [Related]
24. Factors affecting calcium oxalate dihydrate fragmented calculi regrowth.
Costa-Bauzá A; Perelló J; Isern B; Sanchis P; Grases F
BMC Urol; 2006 Jul; 6():16. PubMed ID: 16822299
[TBL] [Abstract][Full Text] [Related]
25. [Studies on the crystallization tendency of calcium oxalate in urine--a study of experimental and computer-assisted determination of the risk of urinary calculi formation].
Berg W; Bothor C; Geyer H
Z Urol Nephrol; 1990 Jul; 83(7):347-57. PubMed ID: 2238876
[TBL] [Abstract][Full Text] [Related]
26. Zeta potential measurement and particle size analysis for a better understanding of urinary inhibitors of calcium oxalate crystallization.
Cao LC; Deng G; Boevé ER; de Bruijn WC; de Water R; Verkoelen CF; Romijn JC; Schröder FH
Scanning Microsc; 1996; 10(2):401-11; discussion 412-4. PubMed ID: 9813619
[TBL] [Abstract][Full Text] [Related]
27. Role of urinary bikunin in the inhibition of calcium oxalate crystallization.
Atmani F; Khan SR
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S385-8. PubMed ID: 10541269
[TBL] [Abstract][Full Text] [Related]
28. Cystine: a promoter of the growth and aggregation of calcium oxalate crystals in normal undiluted human urine.
Martins MC; Meyers AA; Whalley NA; Rodgers AL
J Urol; 2002 Jan; 167(1):317-21. PubMed ID: 11743349
[TBL] [Abstract][Full Text] [Related]
29. [Inhibitory effect of sodium pentosan polysulfate on the formation, growth and aggregation of calcium oxalate in vitro].
Suzuki K; Miyazawa K; Tsugawa R
Nihon Hinyokika Gakkai Zasshi; 1989 Apr; 80(4):526-31. PubMed ID: 2473238
[TBL] [Abstract][Full Text] [Related]
30. [Factors which influence the size of calcium oxalat crystals during their formation from saturated solutions].
Hartung R; Leskovar P
Helv Chir Acta; 1978 Jul; 45(3):247-51. PubMed ID: 701060
[TBL] [Abstract][Full Text] [Related]
31. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
Khan SR; Thamilselvan S
Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696
[TBL] [Abstract][Full Text] [Related]
32. Acute oral calcium-sodium citrate load in healthy males. Effects on acid-base and mineral metabolism, oxalate and other risk factors of stone formation in urine.
Schwille PO; Schmiedl A; Herrmann U; Schwille R; Fink E; Manoharan M
Methods Find Exp Clin Pharmacol; 1997; 19(6):417-27. PubMed ID: 9385591
[TBL] [Abstract][Full Text] [Related]
33. [Studies of sodium pentosan polysulphate (SPP) therapy on the urinary stone disease. Experimental studies on the calcium oxalate crystallization and the effects in healthy subjects].
Fukatani T
Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):246-53. PubMed ID: 1710303
[TBL] [Abstract][Full Text] [Related]
34. Adsorption of naturally occurring polymers onto calcium oxalate crystal surfaces.
Leal JJ; Finlayson B
Invest Urol; 1977 Jan; 14(4):278-83. PubMed ID: 64463
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of growth and aggregation of calcium oxalate crystals in vitro--a comparison of four human proteins.
Grover PK; Moritz RL; Simpson RJ; Ryall RL
Eur J Biochem; 1998 May; 253(3):637-44. PubMed ID: 9654060
[TBL] [Abstract][Full Text] [Related]
36. Effects of inositol hexaphosphate (phytate) on calcium binding, calcium oxalate crystallization and in vitro stone growth.
Saw NK; Chow K; Rao PN; Kavanagh JP
J Urol; 2007 Jun; 177(6):2366-70. PubMed ID: 17509360
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneous nucleation of calcium oxalate crystals in mammalian urine.
Khan SR
Scanning Microsc; 1995 Jun; 9(2):597-614; discussion 614-6. PubMed ID: 8714752
[TBL] [Abstract][Full Text] [Related]
38. [Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro].
Atmani F; Lacour B; Daudon M
Nephrologie; 1996; 17(3):157-62. PubMed ID: 9064564
[TBL] [Abstract][Full Text] [Related]
39. Effect of glycosaminoglycans on calcium oxalate crystal aggregation.
Shirane Y; Yamamoto A; Mizuta K; Kagawa S
Tokushima J Exp Med; 1989 Dec; 36(3-4):81-5. PubMed ID: 2517714
[TBL] [Abstract][Full Text] [Related]
40. Changes in the surface conditioning of calcium-salt crystals treated with physiological and alkaline urine.
Santin M; Motta A; Cannas M
Br J Urol; 1998 Jul; 82(1):97-103. PubMed ID: 9698669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
